AroCell AB announces today that a new peer-reviewed article has been accepted for publication in the BioTechniques journal. The article describes a comparison of AroCell TK 210 ELISA with Abcam TK1 ELISA.
The article is entitled “AroCell TK 210 ELISA for determination of TK1 protein: Age-related reference ranges and comparison with other TK1 assays”, by Kiran Jagarlamudi et al. The aim of the study is to establish the age-related reference ranges of TK1 protein levels in sera from apparently healthy individuals (N=264), and comparison of AroCell TK 210 ELISA with Abcam TK1 ELISA using sera from patients with hematological malignancies (N=62) as well as solid tumours (N=30).
The results of this scientific study demonstrated that the AroCell TK 210 ELISA has higher sensitivity than the Abcam TK1 ELISA for differentiating hematological malignancies and solid tumors from apparently healthy individuals. These results strongly indicate that the AroCell TK210 ELISA is accurate and sensitive enough to be a valuable tool in cancer management compared to other TK1 assays.
“We are delighted with the results of this scientific study, which demonstrate that the AroCell TK 210 ELISA kit has high accuracy and sensitivity compare to other methods”, Michael Brobjer CEO at AroCell.
The publication will soon be available on biotechniques.com and on arocell.com.